Investor Alert – Cybin: Changing the Mental Healthcare Experience

On a mission to revolutionize mental healthcare

Cybin is a biotech company in the psychedelic therapeutic sector. Their team is focused on the development of mental healthcare treatment with a single-minded goal to dramatically improve patient outcomes versus currently available pharmacotherapies.

Their work includes the development of new drug molecules, with a focus on optimizing treatment outcomes through innovative drug delivery systems, concurrent therapy regimens, and technology-driven patient analytics.

For more information on Cybin Inc. (NEO: CYBN, NYSE AMERICAN: CYBN) please click the request investor info button.